Silver nanoparticles in cancer: Therapeutic efficacy and toxicity

Current Medicinal Chemistry

Volumn 20, Issue 6, 2013, Pages 772-781

  Ong, C ^a   Lim, J Z Z ^a   Ng, C T ^a,b   Li, J J ^a,b   Yung, L Y L ^b   Bay, B H ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antimicrobial agents; Biomedical applications; Cancer detection; Cancer therapy; In vitro approach; In vivo study; Nanomaterials; Nanotechnology; Silver nanoparticles; Toxicity

Indexed keywords

ANTIINFECTIVE AGENT; SILVER NANOPARTICLE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; BIOMEDICINE; BLOOD TOXICITY; BRAIN TOXICITY; CANCER THERAPY; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG TOXICITY; EMBRYO DEVELOPMENT; HAZARD RATIO; HUMAN; IC 50; IN VIVO STUDY; LIVER TOXICITY; LUNG TOXICITY; NANOMEDICINE; NANOTECHNOLOGY; NANOTOXICITY; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PHOTOACOUSTIC MICROSCOPY; RAMAN SPECTROMETRY; RISK ASSESSMENT; SKIN TOXICITY; TUMOR GROWTH;

EID: 84877946668     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320060003     Document Type: Article

References (111)

1. Nowack, B.; Bucheli, T.D. Occurrence, behavior and effects of nanoparticles in the environment. Environ. Pollut., 2007, 150(1), 5-22. (Pubitemid 47592962)
2. Powell, M.C.; Kanarek, M.S. Nanomaterial health effects-part 2: Uncertainties and recommendations for the furure. WMJ., 2006, 105(3), 18-23. (Pubitemid 43735903)
3. SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). Opinion on the Scientific basis for the definition of the term "nanomaterial". European Comission, European Union, 8 December, 2010.
4. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Persp., 2005, 113(7), 823-839. (Pubitemid 40984181)
5. Lanone, S.; Boczkowski, J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr. Mol. Med., 2006, 6(6), 651-663. (Pubitemid 44377764)
6. Bianco, A.; Kostarelos, K.; Prato, M. Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin. Drug Deliv., 2008, 5(3), 331-342. (Pubitemid 351454382)
7. Bhattacharya, R.; Mukherjee, P. Biological properties of "naked" metal nanoparticles. Adv. Drug Deliv. Rev., 2008, 60(11), 1289-1306.
8. Li, Y.F.; Chen, C. Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small, 2011, 7(21), 2965-2980.
9. Cheng, Z.; Elias, D.R.; Kamat, N.P.; Johnston, E.D.; Poloukhtine, A.; Popik, V.; Hammer, D.A.; Tsourkas, A. Improved tumor targeting of polymer-based nanovesicles using polymer-lipid blends. Bioconjug. Chem., 2011, 22(10), 2021-2029.
10. Lucarelli, M.; Gatti, A.M.; Savarino, G.; Quattroni, P.; Martinelli, L.; Monari, E.; Boraschi, D. Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur. Cytokine Netw., 2004, 15(4), 339-346. (Pubitemid 40127659)
11. Powell, M.C.; Kanarek, M.S. Nanomaterial health effects-part 1: background and current knowledge. WMJ, 2006, 105(2), 16-20.
12. Yih, T.C.; Al-Fandi, M. Engineered nanoparticles as precise drug delivery systems. J. Cell Biochem., 2006, 97(6), 1184-1190.
13. Ahamed, M.; Alsalhi, M.S.; Siddiqui, M.K. Silver nanoparticle applications and human health. Clin. Chim. Acta., 2010, 411(23-24), 1841-1848.
14. Singh, M.; Singh, S.; Prasada, S.; Gambhir, I.S. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Dig. J. Nanomater. and Bios., 2008, 3(3), 115-122.
15. Tian, J.; Wong, K.K.; Ho, C.M.; Lok, C.N.; Yu, W.Y.; Che, C.M.; Chiu, J.F.; Tam, P.K. Topical delivery of silver nanoparticles promotes wound healing. Chem. Med. Chem., 2007, 2(1), 129-136.
16. Rujitanaroj, P.-o.; Pimpha, N.; Supaphol, P. Wound-dressing materials with antibacterial activity from electrospun gelatin fiber mats containing silver nanoparticles. Polymer, 2008, 49(21), 4723-4732.
17. Furno, F.; Morley, K.S.; Wong, B.; Sharp, B.L.; Arnold, P.L.; Howdle, S.M.; Bayston, R.; Brown, P.D.; Winship, P.D.; Reid, H.J. Silver nanoparticles and polymeric medical devices: A new approach to prevention of infection? J. Antimicrob. Chemother., 2004, 54(6), 1019-1024. (Pubitemid 40136734)
18. Foldbjerg, R.; Dang, D.A.; Autrup, H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch. Toxicol., 2011, 85(7), 743-750.
19. Ip, M.; Lui, S.L.; Poon, V.K.; Lung, I.; Burd, A. Antimicrobial activities of silver dressings: An in vitro comparison. J. Med. Microbiol., 2006, 55(Pt 1), 59-63. (Pubitemid 43031239)
20. Johnston, H.J.; Hutchison, G.; Christensen, F.M.; Peters, S.; Hankin, S.; Stone, V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol., 2010, 40(4), 328-346.
21. Liu, Y.; Miyoshi, H.; Nakamura, M. Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer., 2007, 120(12), 2527-2537. (Pubitemid 46651272)
22. Jain, K.K. Advances in the field of nanooncology. BMC Med., 2010, 8, 83.
23. Pumera, M. Nanotoxicology: the molecular science point of view. Chem. Asian J., 2011, 6(2), 340-348.
24. Krug, H.F.; Wick, P. Nanotoxicology: An interdisciplinary challenge. Angew. Chem. Int. Ed. Engl., 2011, 50(6), 1260-1278.
25. Shvedova, A.A.; Kisin, E.R.; Porter, D.; Schulte, P.; Kagan, V.E.; Fadeel, B.; Castranova, V. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus? Pharmacol. Ther., 2009, 121(2), 192-204.
26. Kagan, V.E.; Bayir, H.; Shvedova, A.A. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine, 2005, 1(4), 313-316. (Pubitemid 43963640)
27. Fadeel, B.; Garcia-Bennett, A.E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug. Deliv. Rev., 2010, 62 (3), 362-374.
28. Hoet, P.; Legiest, B.; Geys, J.; Nemery, B. Do nanomedicines require novel safety assessments to ensure their safety for long-Term human use? Drug Saf., 2009, 32(8), 625-636.
29. Homan, K.; Shah, J.; Gomez, S.; Gensler, H.; Karpiouk, A.; Brannon-Peppas, L.; Emelianov, S. Silver nanosystems for photoacoustic imaging and image-guided therapy. J. Biomed. Opt., 2010, 15(2), 021316.
30. Kneipp, J.; Kneipp, H.; Wittig, B.; Kneipp, K. Novel optical nanosensors for probing and imaging live cells. Nanomedicine, 2010, 6(2), 214-226.
31. Kumar, A.; Vemula, P.K.; Ajayan, P.M.; John, G. Silver nanoparticle embedded antimicrobial paints based on vegetable oil. Nat. Mater., 2008, 7(3), 236-241. (Pubitemid 351311299)
32. Quadros, M.E.; Marr, L.C. Environmental and human health risks of aerosolized silver nanoparticles. J. Air Waste Manag. Assoc., 2010, 60(7), 770-781.
33. Thomas, V.; Yallapu, M.M.; Sreedhar, B.; Bajpai, S.K. Fabrication, characterization of chitosan/nanosilver film and its potential antibacterial application. J. Biomater. Sci. Polym. Ed., 2009, 20(14), 2129-2144.
34. Eby, D.M.; Luckarift, H.R.; Johnson, G.R. Hybrid antimicrobial enzyme and silver nanoparticle coatings for medical instruments. ACS Appl. Mater. Interfaces., 2009, 1(7), 1553-1560.
35. Wong, K.K.; Cheung, S.O.; Huang, L.; Niu, J.; Tao, C.; Ho, C.M.; Che, C.M.; Tam, P.K. Further evidence of the anti-inflammatory effects of silver nanoparticles. Chem. Med. Chem., 2009, 4(7), 1129-1135.
36. Liu, X.; Lee, P.Y.; Ho, C.M.; Lui, V.C.; Chen, Y.; Che, C.M.; Tam, P.K.; Wong, K.K. Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing. Chem. Med. Chem., 2010, 5(3), 468-475.
37. WHO Cancer. http://www.who.int/cancer/en/(Accessed Oct 21, 2012).
38. Boisselier, E.; Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev., 2009, 38(6), 1759-1782.
39. Iyer, A.K.; He, J.; Amiji, M.M. Image-guided nanosystems for targeted delivery in cancer therapy. Curr. Med. Chem., 2012, 19(19), 3230-3240.
40. Deepa, G.; Kumar, N.A.; Pillai, J.J.; Kumar, G.S. Polymer nanoparticles -A novel strategy for administration of paclitaxel in cancer chemotherapy. Curr. Med. Chem., 2012. [Epub ahead of print]
41. Yoffe, S.; Leshuk, T.; Everett, P.; Gu, F. Superparamagnetic iron oxide nanoparticles (SPIONs): synthesis and surface modification techniques for use with MRI and other biomadical applications. Curr. Pharm. Des., 2012. Epub ahead of print]
42. Holgado, M.A.; Martin-Banderas, L.; Alvarez-Fuentes, J.; Fernandez-Arevalo, M.; Arias, J.L. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules. Curr. Med. Chem., 2012, 19(19), 3188-3195.
43. Roy, P.; Das, S.; Mondal, A.; Chatterji, U.; Mukherjee, A. Nanoparticle engineering enhances anticancer efficacy of andrographolide in MCF-7 cells and mice bearing EAC. Curr. Pharm. Biotechnol., 2012. [Epub ahead of print]
44. Sperling, R.A.; Rivera Gil, P.; Zhang, F.; Zanella, M.; Parak, W.J. Biological applications of gold nanoparticles. Chem. Soc. Rev., 2008, 37(9), 1896-1908.
45. Hainfeld, J.F.; Slatkin, D.N.; Smilowitz, H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol., 2004, 49(18), N309-315. (Pubitemid 39302700)
46. Loo, C.; Lowery, A.; Halas, N.; West, J.; Drezek, R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett., 2005, 5(4), 709-711. (Pubitemid 40609745)
47. Chen, Y.H.; Tsai, C.Y.; Huang, P.Y.; Chang, M.Y.; Cheng, P.C.; Chou, C.H.; Chen, D.H.; Wang, C.R.; Shiau, A.L.; Wu, C.L. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol. Pharm., 2007, 4(5), 713-722.
48. Tang, L.; Dong, C.; Ren, J. Highly sensitive homogenous immunoassay of cancer biomarker using silver nanoparticles enhanced fluorescence correlation spectroscopy. Talanta, 2010, 81(4-5), 1560-1567.
49. Jun, B.H.; Noh, M.S.; Kim, J.; Kim, G.; Kang, H.; Kim, M.S.; Seo, Y.T.; Baek, J.; Kim, J.H.; Park, J.; Kim, S.; Kim, Y.K.; Hyeon, T.; Cho, M.H.; Jeong, D.H.; Lee, Y.S. Multifunctional silver-embedded magnetic nanoparticles as SERS nanoprobes and their applications. Small, 2010, 6(1), 119-125.
50. Mahmood, M.; Casciano, D.A.; Mocan, T.; Iancu, C.; Xu, Y.; Mocan, L.; Iancu, D.T.; Dervishi, E.; Li, Z.; Abdalmuhsen, M.; Biris, A.R.; Ali, N.; Howard, P.; Biris, A.S. Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines. J. Appl. Toxicol., 2010, 30(1), 74-83.
51. Carmeliet, P. Angiogenesis in life, disease and medicine. Nature, 2005, 438(7070), 932-936. (Pubitemid 43093958)
52. Cross, M.J.; Claesson-Welsh, L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci., 2001, 22(4), 201-207. (Pubitemid 32244307)
53. Gurunathan, S.; Lee, K.J.; Kalishwaralal, K.; Sheikpranbabu, S.; Vaidyanathan, R.; Eom, S.H. Antiangiogenic properties of silver nanoparticles. Biomaterials, 2009, 30(31), 6341-6350.
54. Kalishwaralal, K.; Banumathi, E.; Ram Kumar Pandian, S.; Deepak, V.; Muniyandi, J.; Eom, S.H.; Gurunathan, S. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf. B. Biointerfaces., 2009, 73(1), 51-57.
55. Kemp, M.M.; Kumar, A.; Mousa, S.; Dyskin, E.; Yalcin, M.; Ajayan, P.; Linhardt, R.J.; Mousa, S.A. Gold and silver nanoparticles conjugated with heparin derivative possess anti-Angiogenesis properties. Nanotechnology, 2009, 20(45), 455104.
56. Mukherjee, P.; Bhattacharya, R.; Wang, P.; Wang, L.; Basu, S.; Nagy, J.A.; Atala, A.; Mukhopadhyay, D.; Soker, S. Antiangiogenic properties of gold nanoparticles. Clin. Cancer Res., 2005, 11(9), 3530-3534. (Pubitemid 40627908)
57. Sheikpranbabu, S.; Kalishwaralal, K.; Venkataraman, D.; Eom, S.H.; Park, J.; Gurunathan S. Silver nanoparticles inhibit VEGF-And IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J. Nanobiotechnology, 2009, 7, 8.
58. Nallathamby, P.D.; Xu, X.H. Study of cytotoxic and therapeutic effects of stable and purified silver nanoparticles on tumor cells. Nanoscale, 2010, 2(6), 942-952.
59. Warheit, D.B.; Borm, P.J.; Hennes, C.; Lademann, J. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal. Toxicol., 2007, 19(8), 631-643. (Pubitemid 46788950)
60. Scown, T.M.; Santos, E.M.; Johnston, B.D.; Gaiser, B.; Baalousha, M.; Mitov, S.; Lead, J.R.; Stone, V.; Fernandes, T.F.; Jepson, M.; van Aerle, R.; Tyler, C.R. Effects of aqueous exposure to silver nanoparticles of different sizes in rainbow trout. Toxicol. Sci., 2010, 115(2), 521-534.
61. Sur, I.; Cam, D.; Kahraman, M.; Baysal, A.; Culha, M. Interaction of multifunctional silver nanoparticles with living cells. Nanotechnology, 2010, 21(17), 175104.
62. Ahamed, M.; Karns, M.; Goodson, M.; Rowe, J.; Hussain, S.M.; Schlager, J.J.; Hong, Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol. Appl. Pharmacol., 2008, 233(3), 404-410.
63. Damoiseaux, R.; George, S.; Li, M.; Pokhrel, S.; Ji, Z.; France, B.; Xia, T.; Suarez, E.; Rallo, R.; Madler, L.; Cohen, Y.; Hoek, E.M.; Nel, A. No time to lose-high throughput screening to assess nanomaterial safety. Nanoscale, 2011, 3(4), 1345-1360.
64. Arora, S.; Jain, J.; Rajwade, J.M.; Paknikar, K.M. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol. Lett., 2008, 179(2), 93-100.
65. Asharani, P.V.; Low Kah Mun, G.; Hande, M.P.; Valiyaveettil, S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano, 2009, 3(2), 279-290.
66. Hussain, S.M.; Hess, K.L.; Gearhart, J.M.; Geiss, K.T.; Schlager, J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro, 2005, 19(7), 975-983. (Pubitemid 41563236)
67. Piao, M.J.; Kang, K.A.; Lee, I.K.; Kim, H.S.; Kim, S.; Choi, J.Y.; Choi, J.; Hyun, J.W. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol. Lett., 2011, 201(1), 92-100.
68. Miura, N.; Shinohara, Y. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem. Biophys. Res. Commun., 2009, 390(3), 733-737.
69. Hackenberg, S.; Scherzed, A.; Kessler, M.; Hummel, S.; Technau, A.; Froelich, K.; Ginzkey, C.; Koehler, C.; Hagen, R.; Kleinsasser, N. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol. Lett., 2011, 201(1), 27-33.
70. Jun, E.A.; Lim, K.M.; Kim, K.; Bae, O.N.; Noh, J.Y.; Chung, K.H.; Chung, J.H. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology, 2011, 5(2), 157-167.
71. Solum, N.O. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler. Thromb. Vasc. Biol., 1999, 19(12), 2841-2846. (Pubitemid 30029808)
72. Lee, M.Y.; Bae, O.N.; Chung, S.M.; Kang, K.T.; Lee, J.Y.; Chung, J.H. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: A contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol., 2002, 179(2), 83-88.
73. Nemmar, A.; Hoet, P.H.; Vandervoort, P.; Dinsdale, D.; Nemery, B.; Hoylaerts, M.F. Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: role of P-selectin. J. Thromb. Haemost., 2007, 5(6), 1217-1226. (Pubitemid 46902124)
74. Shrivastava, S.; Bera, T.; Singh, S.K.; Singh, G.; Ramachandrarao, P.; Dash, D. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano, 2009, 3(6), 1357-1364.
75. Fadeel, B.; Ahlin, A.; Henter, J.I.; Orrenius, S.; Hampton, M.B. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood, 1998, 92(12), 4808-4818. (Pubitemid 29005884)
76. Wei, L.; Tang, J.; Zhang, Z.; Chen, Y.; Zhou, G.; Xi, T. Investigation of the cytotoxicity mechanism of silver nanoparticles in vitro. Biomed. Mater., 2010, 5(4), 044103.
77. Swanson, J.A. Shaping cups into phagosomes and macropinosomes. Nat. Rev. Mol. Cell Biol., 2008, 9(8), 639-649.
78. Wijnhoven, S.; Peijnenburg, W.; Herberts, C.; Hagens, W.; Oomen, A.; Heugens, E.; Roszek, B.; Bisschops, J.; Gosens, I.; van de Meent, D.; Dekkers, S.; deJong, W.; van Zijverden, M.; Sips, A.; Geertsma, R. Nanosilver: A review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology, 2009, 3(2), 109-138.
79. Fischer, H.C.; Chan, W.C. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol., 2007, 18(6), 565-571.
80. Sanchez, V.C.; Pietruska, J.R.; Miselis, N.R.; Hurt, R.H.; Kane, A.B. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2009, 1(5), 511-529.
81. Loeschner, K.; Hadrup, N.; Qvortrup, K.; Larsen, A.; Gao, X.; Vogel, U.; Mortensen, A.; Lam, H.R.; Larsen, E.H. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre. Toxicol., 2011, 8, 18.
82. Kim, Y.S.; Kim, J.S.; Cho, H.S.; Rha, D.S.; Kim, J.M.; Park, J.D.; Choi, B.S.; Lim, R.; Chang, H.K.; Chung, Y.H.; Kwon, I.H.; Jeong, J.; Han, B.S.; Yu, I.J. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol., 2008, 20(6), 575-583. (Pubitemid 351601408)
83. Takenaka, S.; Karg, E.; Roth, C.; Schulz, H.; Ziesenis, A.; Heinzmann, U.; Schramel, P.; Heyder, J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health. Perspect., 2001, 109, 547-551. (Pubitemid 32834568)
84. Ji, J.H.; Jung, J.H.; Kim, S.S.; Yoon, J.U.; Park, J.D.; Choi, B.S.; Chung, Y.H.; Kwon, I.H.; Jeong, J.; Han, B.S.; Shin, J.H.; Sung, J.H.; Song, K.S.; Yu, I.J. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol., 2007, 19(10), 857-871. (Pubitemid 47237748)
85. Almeida, J.P.; Chen, A.L.; Foster, A.; Drezek, R. In vivo biodistribution of nanoparticles. Nanomedicine (Lond.), 2011, 6(5), 815-835.
86. Yu, L.E.; Yung, L.Y.L.; Ong, C.N.; Tan, Y.L.; Balasubramaniam, K.S.; Hartono, D.; Shui, G.; Wenk, M.R.; Ong, W.Y. Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nanotoxicology, 2007, 1(3), 235-242. (Pubitemid 350179071)
87. Sung, J.H.; Ji, J.H.; Yoon, J.U.; Kim, D.S.; Song, M.Y.; Jeong, J.; Han, B.S.; Han, J.H.; Chung, Y.H.; Kim, J.; Kim, T.S.; Chang, H.K.; Lee, E.J.; Lee, J.H.; Yu, I.J. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol., 2008, 20 (6), 567-574. (Pubitemid 351601407)
88. Sung, J.H.; Ji, J.H.; Song, K.S.; Lee, J.H.; Choi, K.H.; Lee, S.H.; Yu, I.J. Acute inhalation toxicity of silver nanoparticles. Toxicol. Ind. Health, 2011, 27(2), 149-154.
89. Riviere, J.E. Pharmacokinetics of nanomaterials: An overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2009, 1(1), 26-34.
90. Furchner, J.E.; Richmond, C.R.; Drake, G.A. Comparative metabolism of radionuclides in mammals-IV. Retention of silver-110m in the mouse, rat, monkey and dog. Health Phys., 1968, 15(6), 505-514.
91. Mates, J.M.; Perez-Gomez, C.; Nunez de Castro, I. Antioxidant enzymes and human diseases. Clin. Biochem., 1999, 32(8), 595-603. (Pubitemid 30039087)
92. Reynolds, A.; Laurie, C.; Mosley, R.L.; Gendelman, H.E. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol., 2007, 82, 297-325.
93. Halliwell, B. Oxidative stress and neurodegeneration: where are we now? J. Neurochem., 2006, 97(6), 1634-1658. (Pubitemid 43873658)
94. Kim, S.; Choi, J.E.; Choi, J.; Chung, K.H.; Park, K.; Yi, J.; Ryu, D.Y. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. In Vitro, 2009, 23(6), 1076-1084.
95. Oberdorster, G.; Elder, A.; Rinderknecht, A. Nanoparticles and the brain: cause for concern? J. Nanosci. Nanotechnol., 2009, 9(8), 4996-5007.
96. Tang, J.; Xiong, L.; Wang, S.; Wang, J.; Liu, L.; Li, J.; Wan, Z.; Xi, T. Influence of silver nanoparticles on neurons and blood-brain barrier via subcutaneous injection in rats. Appl. Surf. Sci., 2008, 255(2), 502-504.
97. Rahman, M.F.; Wang, J.; Patterson, T.A.; Saini, U.T.; Robinson, B.L.; Newport, G.D.; Murdock, R.C.; Schlager, J.J.; Hussain, S.M.; Ali, S.F. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett., 2009, 187(1), 15-21.
98. Powers, C.M.; Yen, J.; Linney, E.A.; Seidler, F.J.; Slotkin, T.A. Silver exposure in developing zebrafish (Danio rerio): persistent effects on larval behavior and survival. Neurotoxicol. Teratol., 2010, 32(3), 391-397.
99. Powers, C.M.; Levin, E.D.; Seidler, F.J.; Slotkin, T.A. Silver exposure in developing zebrafish produces persistent synaptic and behavioral changes. Neurotoxicol. Teratol., 2011, 33(2), 329-332.
100. Jain, J.; Arora, S.; Rajwade, J.M.; Omray, P.; Khandelwal, S.; Paknikar, K.M. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol. Pharm., 2009, 6(5), 1388-1401.
101. Samberg, M.E.; Oldenburg, S.J.; Monteiro-Riviere, N.A. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ. Health Perspect., 2010, 118(3), 407-413.
102. Draize, J.H.; Woodard, G.; Calvery, H.O. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Thr., 1944, 82(3), 377-390.
103. Al-Gubory, K.H.; Fowler, P.A.; Garrel, C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int. J. Biochem. Cell Biol., 2010, 42(10), 1634-1650.
104. Arrigo, A.P.; Simon, S. Expression and functions of heat shock proteins in the normal and pathological mammalian eye. Curr. Mol. Med., 2010, 10 (9), 776-793.
105. Lee, K.J.; Nallathamby, P.D.; Browning, L.M.; Osgood, C.J.; Xu, X.H. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS Nano, 2007, 1(2), 133-143.
106. Asharani, P.V.; Lianwu, Y.; Gong, Z.; Valiyaveettil, S. Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology, 2011, 5(1), 43-54.
107. Li, P.W.; Kuo, T.H.; Chang, J.H.; Yeh, J.M.; Chan, W.H. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol. Lett., 2010, 197(2), 82-87.
108. Blaser, S.A.; Scheringer, M.; Macleod, M.; Hungerbuhler, K. Estimation of cumulative aquatic exposure and risk due to silver: contribution of nanofunctionalized plastics and textiles. Sci. Total Environ., 2008, 390(2-3), 396-409. (Pubitemid 350256822)
109. O'Brien, N.; Cummins, E. Ranking initial environmental and human health risk resulting from environmentally relevant nanomaterials. J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng., 2010, 45(8), 992-1007.
110. Stone, V.; Johnston, H.; Clift, M.J. Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans. Nanobioscience, 2007, 6(4), 331-340. (Pubitemid 350210539)
111. Oberdorster, G.; Gelein, R.M.; Ferin, J.; Weiss, B. Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal. Toxicol., 1995, 7(1), 111-124.